BIO-OPTIONS Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BIO-OPTIONS's estimated annual revenue is currently $1.4M per year.(i)
  • BIO-OPTIONS's estimated revenue per employee is $155,000

Employee Data

  • BIO-OPTIONS has 9 Employees.(i)
  • BIO-OPTIONS grew their employee count by -10% last year.

BIO-OPTIONS's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
EVP, Chief Medical OfficerReveal Email/Phone
3
Sr. Director Biospecimen/Tissue Procurement ProjectsReveal Email/Phone
4
General ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is BIO-OPTIONS?

BIO-OPTIONS is a physician owned and operated provider of human biospecimens for research. We design prospective specimen collection protocols that conform precisely to the requirements of our clients' research studies. We also maintain large in-house libraries of banked biospecimens, including FFPE tissue blocks, frozen tissue and blood, and other biological materials. Associated clinical data is provided, including the status of biomarkers known to be important at the time of collection. In addition we can test banked specimens retrospectively for newly discovered biomarkers, thus greatly increasing the number of specimens available for some research studies. We understand the needs of research scientists as well as those of surgeons and other clinical specimen providers. We ensure that proper protocols are followed, consents are obtained, and that samples are annotated comprehensively. Our nationwide network of US community hospitals and clinics gives us an unsurpassed ability to meet the needs of research groups. BIO-OPTIONS delivers the highest quality biospecimens to researchers. We have ongoing programs with many pharmaceutical and diagnostics companies, both large and small. BIO-OPTIONS is frequently cited as specimen provider in major biotech and biopharm publications and patents.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9-10%N/A
#2
$0.7M9-25%N/A
#3
$1.1M9-25%N/A
#4
$0.7M90%N/A
#5
$0.9M100%N/A